{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:38:03Z","timestamp":1794101883746,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Funding for the Excellent Reserve Talents in the Discipline of Affiliated Hospital of Guizhou Medical University","award":["gyfyxkyc-2023-13"],"award-info":[{"award-number":["gyfyxkyc-2023-13"]}]},{"name":"Guizhou Provincial Science and Technology Projects","award":["Qiankehejichu-ZK[2023]353"],"award-info":[{"award-number":["Qiankehejichu-ZK[2023]353"]}]},{"name":"Cultivation Project of National Natural Science Foundation of China by The Affiliated of Guizhou Medical University","award":["gyfynsfc[2023]-03"],"award-info":[{"award-number":["gyfynsfc[2023]-03"]}]},{"name":"Guizhou Province High-level Innovative Talent Program","award":["gzwijrs 2023-019"],"award-info":[{"award-number":["gzwijrs 2023-019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70891-9","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:02:34Z","timestamp":1725037354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Maowen","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinggui","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"5","key":"70891_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/cld.1061","volume":"17","author":"S Cheemerla","year":"2021","unstructured":"Cheemerla, S. & Balakrishnan, M. Global epidemiology of chronic liver disease. Clin. Liver Dis. (Hoboken) 17(5), 365\u2013370 (2021).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"issue":"2","key":"70891_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bpg.2011.02.003","volume":"25","author":"L Castera","year":"2011","unstructured":"Castera, L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract. Res. Clin. Gastroenterol. 25(2), 291\u2013303 (2011).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"7","key":"70891_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo, A. A., Sheth, S. G. & Chopra, S. Liver biopsy. N. Engl. J. Med. 344(7), 495\u2013500 (2001).","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"70891_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","volume":"69","author":"R Loomba","year":"2020","unstructured":"Loomba, R. & Adams, L. A. Advances in non-invasive assessment of hepatic fibrosis. Gut 69(7), 1343\u20131352 (2020).","journal-title":"Gut"},{"issue":"2","key":"70891_CR5","first-page":"149","volume":"15","author":"M Grigorescu","year":"2006","unstructured":"Grigorescu, M. Noninvasive biochemical markers of liver fibrosis. J. Gastrointest. Liver. Dis. 15(2), 149\u2013159 (2006).","journal-title":"J. Gastrointest. Liver. Dis."},{"issue":"8","key":"70891_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00261-017-1096-5","volume":"42","author":"MG Lubner","year":"2017","unstructured":"Lubner, M. G., Malecki, K., Kloke, J., Ganeshan, B. & Pickhardt, P. J. Texture analysis of the liver at MDCT for assessing hepatic fibrosis. Abdom. Radiol. (NY). 42(8), 2069\u20132078 (2017).","journal-title":"Abdom. Radiol. (NY)."},{"issue":"1","key":"70891_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/hep.29179","volume":"67","author":"E Herrmann","year":"2018","unstructured":"Herrmann, E. et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis. Hepatology. 67(1), 260\u2013272 (2018).","journal-title":"Hepatology."},{"issue":"3","key":"70891_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh, S. et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: A systematic review and meta-analysis of individual participant data. Clin. Gastroenterol. Hepatol. 13(3), 440-451.e6 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"70891_CR9","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao, G. et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology 66(5), 1486\u20131501 (2017).","journal-title":"Hepatology"},{"issue":"2","key":"70891_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero, J. A. et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology 68(2), 723\u2013750 (2018).","journal-title":"Hepatology"},{"issue":"3","key":"70891_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s12072-022-10326-7","volume":"16","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: An update for image biomarker. Hepatol. Int. 16(3), 627\u2013639 (2022).","journal-title":"Hepatol. Int."},{"issue":"2","key":"70891_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: Images are more than pictures. Data. Radiol. 278(2), 563\u2013577 (2016).","journal-title":"Data. Radiol."},{"issue":"9","key":"70891_CR13","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1111\/liv.14555","volume":"40","author":"J Wei","year":"2020","unstructured":"Wei, J. et al. Radiomics in liver diseases: Current progress and future opportunities. Liver Int. 40(9), 2050\u20132063 (2020).","journal-title":"Liver Int."},{"issue":"1","key":"70891_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00330-019-06347-w","volume":"30","author":"FZ Mokrane","year":"2020","unstructured":"Mokrane, F. Z. et al. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules. Eur. Radiol. 30(1), 558\u2013570 (2020).","journal-title":"Eur. Radiol."},{"key":"70891_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.10.057","author":"GW Ji","year":"2019","unstructured":"Ji, G. W. et al. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study. EBioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2019.10.057 (2019).","journal-title":"EBioMedicine"},{"key":"70891_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.09.023","author":"F Liu","year":"2018","unstructured":"Liu, F. et al. Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): A prospective multicenter study. EBioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.023 (2018).","journal-title":"EBioMedicine"},{"issue":"2","key":"70891_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1148\/radiol.2018181197","volume":"290","author":"HJ Park","year":"2019","unstructured":"Park, H. J. et al. Radiomics analysis of gadoxetic acid-enhanced MRI for staging liver fibrosis. Radiology. 290(2), 380\u2013387 (2019).","journal-title":"Radiology."},{"issue":"5\u20136","key":"70891_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/01617346221120070","volume":"44","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. et al. Liver fibrosis assessment using radiomics of ultrasound homodyned-k imaging based on the artificial neural network estimator. Ultrason. Imaging. 44(5\u20136), 229\u2013241 (2022).","journal-title":"Ultrason. Imaging."},{"issue":"3","key":"70891_CR19","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00330-022-09137-z","volume":"33","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: A single-center retrospective study. Eur. Radiol. 33(3), 1653\u20131667 (2023).","journal-title":"Eur. Radiol."},{"issue":"3","key":"70891_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer, P. J. Classification of chronic viral hepatitis: A need for reassessment. J. Hepatol. 13(3), 372\u2013374 (1991).","journal-title":"J. Hepatol."},{"key":"70891_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-006-9018-6","author":"RM O\u2019brien","year":"2007","unstructured":"O\u2019brien, R. M. a caution regarding rules of thumb for variance inflation factors. Quality Quantity https:\/\/doi.org\/10.1007\/s11135-006-9018-6 (2007).","journal-title":"Quality Quantity"},{"issue":"2","key":"70891_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2010","unstructured":"Wai, C. T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. HEPATOLOGY 38(2), 518\u2013526 (2010).","journal-title":"HEPATOLOGY"},{"key":"70891_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21669","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard, A. et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection comparison with liver biopsy and fibrotest. Hepatology https:\/\/doi.org\/10.1002\/hep.21669 (2007).","journal-title":"Hepatology"},{"issue":"8","key":"70891_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","volume":"65","author":"M Lemoine","year":"2016","unstructured":"Lemoine, M. et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut 65(8), 1369\u20131376 (2016).","journal-title":"Gut"},{"issue":"1","key":"70891_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol. 63(1), 237\u2013264 (2015).","journal-title":"J. Hepatol."},{"key":"70891_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00219-y","author":"JC Wang","year":"2020","unstructured":"Wang, J. C. et al. A radiomics-based model on non-contrast CT for predicting cirrhosis: Make the most of image data. Biomark Res. https:\/\/doi.org\/10.1186\/s40364-020-00219-y (2020).","journal-title":"Biomark Res."},{"key":"70891_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2020.08.029","author":"P Hu","year":"2021","unstructured":"Hu, P. et al. A combination model of radiomics features and clinical biomarkers as a nomogram to differentiate nonadvanced from advanced liver fibrosis: A retrospective study. Acad. Radiol. https:\/\/doi.org\/10.1016\/j.acra.2020.08.029 (2021).","journal-title":"Acad. Radiol."},{"issue":"29","key":"70891_CR28","doi-asserted-by":"publisher","first-page":"6663","DOI":"10.3748\/wjg.v22.i29.6663","volume":"22","author":"DW Zeng","year":"2016","unstructured":"Zeng, D. W., Dong, J., Liu, Y. R., Jiang, J. J. & Zhu, Y. Y. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J. Gastroenterol. 22(29), 6663\u20136672 (2016).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"70891_CR29","first-page":"e33744","volume":"15","author":"S Purkayastha","year":"2023","unstructured":"Purkayastha, S., Jha, A. K., Kumar, R., Dayal, V. M. & Jha, S. K. Serum gamma-glutamyl transpeptidase-to-platelet ratio as a noninvasive marker of liver fibrosis in chronic hepatitis B. Cureus. 15(1), e33744 (2023).","journal-title":"Cureus."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70891-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70891-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70891-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:06:09Z","timestamp":1725037569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70891-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70891"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70891-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20230"}}